Neumora Therapeutics, Inc. (NMRA)

CIK 1885522 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Neumora Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Aug 21, 202640001610717-26-000382
Aug 21, 202640001610717-26-000381
Aug 21, 20261440001964306-26-000408
Aug 21, 202640001610717-26-000385
Aug 21, 202640001610717-26-000384
Aug 21, 202640001610717-26-000383
Aug 20, 20261440001964306-26-000403
Aug 19, 20261440001964306-26-000401
Aug 19, 202640001610717-26-000362
Aug 18, 20261440001964306-26-000400
Aug 17, 20261440001964306-26-000398
Aug 14, 202610-Q0001193125-26-350370
Aug 14, 20268-K0001193125-26-350349
Jul 27, 20268-K0001193125-26-316819
Jun 15, 20268-K0001193125-26-270328
May 29, 202640001610717-26-000171
May 29, 20268-K0001193125-26-248244
May 29, 202640001610717-26-000169
May 29, 202640001610717-26-000170
May 29, 202640001610717-26-000174
May 29, 202640001610717-26-000173
May 15, 2026SCHEDULE 13G/A0000905148-26-002417
May 7, 202610-Q0001193125-26-211825
May 7, 20268-K0001193125-26-210310
May 4, 2026SCHEDULE 13G/A0002005369-26-000023